Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_assertion type Assertion NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_head.
- NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_assertion description "[These findings indicate that chronic intake of CNK-602A in a dose that does not affect plasma levels of T3 and T4 inhibits tonic convulsions in SER and suggest that this drug may be an effective treatment for convulsive seizures in patients with epilepsy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_provenance.
- NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_assertion evidence source_evidence_literature NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_provenance.
- NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_assertion SIO_000772 8603636 NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_provenance.
- NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_assertion wasDerivedFrom befree-20140225 NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_provenance.
- NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_assertion wasGeneratedBy ECO_0000203 NP923079.RAUoCR8Tuc6SWJRNn6SzhlwpEo3KoLbfga0CUFkhnHldM130_provenance.